Rockbridge Investment Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-19
Closed -$427 162
2023
Q4
$427 Buy
+19
New +$392 ﹤0.01% 622
2022
Q3
Sell
-15
Closed -$411 141
2022
Q2
$411 Sell
15
-18
-55% -$517 ﹤0.01% 608
2022
Q1
$1.15K Hold
33
﹤0.01% 726
2021
Q4
$1K Hold
33
﹤0.01% 751
2021
Q3
$1K Hold
33
﹤0.01% 699
2021
Q2
$1K Buy
33
+18
+120% +$744 ﹤0.01% 694
2021
Q1
$1K Hold
15
﹤0.01% 676
2020
Q4
$1K Hold
15
﹤0.01% 651
2020
Q3
$0 Hold
15
﹤0.01% 646
2020
Q2
$0 Buy
+15
New +$434 ﹤0.01% 625

Other funds holding AVNS

Rockbridge Investment Management's AVNS Position: Q1 2024 in Review

Rockbridge Investment Management sold out of Avanos Medical (AVNS) in Q1 2024, closing a stake of 19 shares — an estimated $427 sold.

Rockbridge Investment Management first reported a position in AVNS in Q2 2020 and held it in 10 quarters. The position peaked at $1.15K in Q1 2022. 261 funds tracked by Wall St. Rank hold AVNS as of Q1 2024.

  • Rockbridge Investment Management reported no remaining Avanos Medical position as of Q1 2024 after selling out during the quarter.
  • Rockbridge Investment Management sold 19 Avanos Medical shares in Q1 2024, an estimated $427.
  • Rockbridge Investment Management first reported a position in Avanos Medical in Q2 2020 and held it in 10 quarters.
  • Rockbridge Investment Management's Avanos Medical position peaked at $1.15K in Q1 2022.
  • 261 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2024.

Based on Rockbridge Investment Management's 13F filing for Q1 2024, filed 15 May 2024.